ETFs most similar to GNOM
The funds whose holdings overlap Global X Genomics & Biotechnology ETF the most, by weight. as of Oct 9, 2026issuer data
By holdings overlap
| Fund | Category | Overlap with GNOM | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| GNOMGlobal X Genomics & Biotechnology ETF | Biotech & Health Innovation | — | 0.50% | $101M | +63.4% | 0.94% | |
| ARKGARK Genomic Revolution ETF | Biotech & Health Innovation | 43% | 0.75% | $2.1B | +59.7% | — | side by side |
| IDNAiShares Genomics Immunology and Healthcare ETF | Biotech & Health Innovation | 30% | 0.47% | $320M | +69.9% | 0.67% | side by side |
| WDNAWisdomTree BioRevolution Fund | Biotech & Health Innovation | 30% | 0.45% | $4.7M | +34.4% | 3.28% | side by side |
| PBEInvesco Biotechnology & Genome ETF | Biotech & Health Innovation | 29% | 0.58% | $422M | +34.5% | 1.38% | side by side |
| BBHVanEck Biotech ETF | Biotech & Health Innovation | 28% | 0.35% | $485M | +36.9% | 0.40% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.